Pfizer, BioNTech to Develop mRNA Shingles Vaccine
Pfizer and BioNTech are working to develop an mRNA-based shingles vaccine following the success of the COVID-19 shot. This latest collaboration will mark the third time the pharmaceutical companies have worked together on a vaccine.
More Videos
Zoom for Pets? Joe Spector’s Dutch Is Bringing Telehealth to the Animal Kingdom
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Meet ChatHUE: The AI-Powered Paint Tool You Didn’t Know You Needed!
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
The Return of Supersonic: Boom’s Test Flight and the Future of Faster Travel
Blake Scholl, Founder & CEO of Boom Supersonic, shares how he launched the company to building the future of flight with test flights and major airline deals.
Earnings Season Heats Up: Analyzing Bank Performance and Market Implications
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Tesla’s Wild Ride: Elon Musk, Robo-Taxis, and the Road Ahead
Jack Ewing of The New York Times unpacks Tesla’s delivery slump, Musk’s political clash with Trump, robo-taxis, and the current state of Dogecoin.
Are Millennials and Gen Z Moving On from Spirits? Bacardi’s Tony Latham Weighs In
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
